Articles tagged with Vaccine Research
Scientists have modified mRNA vaccines to include the cytokine IL-12, enhancing T cell responses and improving protection against diseases such as SARS-CoV-2, influenza, melanoma, and listeria infection. The study's findings suggest a promising approach to enhance immune stimulation against cancer and other pathogens.
Researchers at Cornell University have developed a new lipid nanoparticle that replaces PEG with poly(carboxybetaine) to improve mRNA vaccine delivery. This stealthy material helps vaccines evade the immune system while inducing targeted immune responses, making it more effective for cancer vaccines.
Researchers from the University of Cincinnati have engineered bacteria to deliver antiviral therapies and vaccines orally, bypassing traditional methods. The engineered bacteria use outer-membrane vesicles as self-propelled delivery vehicles, targeting mucosal surfaces to provide mucosal immunity.
A new study by University of Illinois researchers highlights the need for flexible approaches to reach diverse audiences with disease prevention strategies. The findings underscore that there is no one-size-fits-all solution to public health challenges, and understanding people's value systems can help inform policy recommendations.
Researchers have developed a cheap and sustainable way to produce ionisable lipids from cashew nutshell liquid, a by-product of the cashew industry. This breakthrough could transform the future of vaccine production and support Africa's target of producing 60% of its vaccines locally by 2040.
Researchers from Amsterdam UMC have made a breakthrough in developing an HIV vaccine with a germline-targeting strategy, inducing immune responses in participants. The phase one trial showed promising results, suggesting the potential for this approach to be further developed into a vaccine.
A new AI model, EVE-Vax, uses evolutionary data to predict viral proteins and design future-proof vaccines against rapidly mutating viruses like SARS-CoV-2. By analyzing millions of years of genetic information, the model can create brand-new proteins with the same immune response as real viruses.
Researchers from Japan evaluate the LC16m8 vaccine, an attenuated vaccinia virus strain, for its efficacy and safety against mpox. The study confirms the vaccine's ability to induce strong immune responses and protect against mpox in mice, monkeys, and humans.
Researchers discovered 500 cryptic peptides found only in pancreatic tumors, which could be targeted by vaccines or engineered T cells to attack the cancer. The peptides were identified using immunopeptidomics and shown to slow down tumor growth in mice.
Scientists have discovered a novel way to enhance the effectiveness of vaccines by boosting stem cell-like memory CD8+ T cells, which can provide decades-long immunity. The study uses mRNA vaccine technology to increase the formation of these cells, offering a promising solution for viruses and cancer therapies.
A novel vaccine platform uses genetically fused antigen to albumin, which is actively transported across the mucosal barrier by FcRn receptor. This results in protective systemic and mucosal antibody responses against SARS-CoV-2 and influenza A.
A new study from Murdoch University confirms that COVID-19 vaccinations do not cause significant metabolic changes. The research monitored 167 metabolic markers in 33 participants over 480 days post-vaccination, showing no significant impact on key health indicators.
Scientists discovered that receiving a booster vaccine in the same arm as the first dose generates a more effective immune response quickly. Memory B cells interact with 'primed' macrophages in lymph nodes to produce high-quality antibodies.
The CoVaRR-Net network successfully bridged critical research and public health gaps exposed by the COVID-19 pandemic through interdisciplinary collaboration and innovative approaches like wastewater surveillance. Its achievements include 139 peer-reviewed publications, evidence-based public health decisions, and a global leader in ear...
A recent study by Stanford Medicine researchers warns that measles and other diseases may make a comeback in the US if immunization rates drop. The study found that even at current levels, measles may become endemic within two decades, leading to an estimated 851,300 cases over 25 years.
A landmark study found that a single oral dose of baloxavir marboxil significantly reduces influenza transmission within households. Conducted across 15 countries, the CENTERSTONE trial provides robust evidence for an antiviral treatment's potential to curb the spread of influenza.
Researchers found a significant difference in parental support for adolescent consent when the question was framed using "Mature Minor Doctrine" versus describing specific scenarios. The study suggests that clear and detailed information can greatly impact parents' opinions on these issues.
The study found that influenza vaccination rates increased for Black and Hispanic older adults in rural areas, while decreasing for some white older adults. Determining the reasons behind these disparities is crucial for future research.
Researchers found a novel virus in the model green alga Chlamydomonas reinhardtii, which is the largest temperate virus discovered to date with a latent infection cycle. The discovery sheds light on potential biotechnological applications, including gene editing.
Researchers found that full-genome differences between rotavirus strains influence vaccine effectiveness, highlighting the need for a broader approach to vaccine design. The study's results suggest that vaccines should be designed based on the whole genome of circulating strains, rather than just two surface proteins.
Researchers have developed an effective approach to tackle intestinal pathogens by administering oral vaccinations combined with harmless bacteria that starve out pathogenic microbes. This method has shown promising results in preventing colonization with salmonella and effectively tackling established E. coli bacteria.
A new study by researchers at McGill University found that annual COVID-19 vaccine booster doses help avoid breakthrough infections in people with immune-mediated inflammatory diseases. The study tracked 366 patients across Canada and used saliva PCR tests and antibody measurements, offering a more precise picture of infection risks.
A new study reveals Japanese citizens broadly susceptible to illiberal narratives, posing risks to Japan's political discourse. The research found that illiberal narratives exert a stronger influence than mainstream democratic messaging.
Researchers develop AI model to predict novel mutations in protein sequences, combining grammatical and semantic changes. The method uses all available information about the sequence and mutations to create a more accurate prediction model.
Researchers at Lancaster University discovered a new type of vaccine-specific scepticism, where some people perceive COVID-19 vaccines as 'not a vaccine' compared to MMR. This phenomenon may also apply to the flu vaccine, highlighting the need for clear public health messaging.
Scientists at Sanford Burnham Prebys developed a new method of generating antibodies by fusing two immune system proteins, enabling the creation of stable monoclonal antibodies. This breakthrough has potential applications in diagnosing and monitoring diseases such as lupus and cancers.
Thomas Jefferson University has initiated a phase 1 clinical trial for a Lassa virus (LASV) vaccine, currently enrolling healthy volunteers. The vaccine's safety and immunogenicity will be assessed in both the rabies virus and LASV.
Researchers found that mice receiving both doses of COVID-19 vaccine in the same limb had a faster initial antibody response. Long-term immunity was similar between vaccination approaches.
A new study has found that sleep debt and night shifts increase the risk of several common infections in nurses. The research, which analyzed data from 1,335 Norwegian nurses, reveals a clear link between slept debt, night work, and infection risk.
The influenza vaccine provided moderate protection against influenza A strains, but strong protection against influenza B. The vaccine was most effective in preventing severe disease among children and adolescents, with a high effectiveness rate.
A recent study from the University of Kansas found that people tend to prefer AI chatbots when discussing sensitive or embarrassing topics like health information, due to their anonymity and nonjudgmental nature. However, when individuals are angry, they still prefer human interaction.
This study identified PIBP4, a PRA protein, as a crucial component of the PigmR-mediated immune signaling pathway in rice. The absence of PIBP4 and its interacting partner OsRab5a compromised blast resistance by disrupting PigmR's microdomain localization.
Researchers at La Jolla Institute for Immunology have discovered a human antibody called mAb 3A6 that may prove useful against deadly outbreaks. The antibody was isolated from an Ebola survivor and found to block infection by binding to the viral stalk, offering protection at a very low dose.
A new University of Virginia study found that providing clear information and collaborative learning sessions between patients and healthcare providers increased willingness to get vaccinated. Sixty-three percent of patients reported a strong recommendation from their healthcare provider motivated them to get vaccinated.
A recent study found that cold temperatures allow the bird pink eye pathogen to survive on bird feeders for up to seven days, causing more severe disease in birds compared to warmer temperatures. Regular cleaning of feeder surfaces with bleach can help mitigate the spread of the disease.
A study of 1,700 people found that those who consumed more conservative news were less likely to be vaccinated, but a diverse media diet made them more likely to get vaccinated. People who got their news from an ideologically diverse array of sources were more critical thinkers and less likely to be misled by misinformation.
A therapeutic HPV vaccine targeting HPV16 could potentially eliminate precancerous cervical lesions, according to a phase II clinical trial. The vaccine showed significant regression and reduced lesion size in patients with HPV16-positive high-grade cervical intraepithelial neoplasia.
Researchers developed a nanoparticle-based vaccine that generates antibodies targeting conserved regions of sarbecovirus receptor-binding proteins, offering broader protection against multiple strains. The vaccine demonstrated strong antibody responses and protection in animal studies against diverse SARS-CoV-2 and other sarbecoviruses.
A new longitudinal study has provided unprecedented insights into human papillomavirus (HPV) infection dynamics. The study found that non-persistent infections exhibit a plateau in viral load before rapidly declining, while chronic infections show a strong correlation between immune cells and virus production. This research could infor...
Researchers found that rotavirus protein NSP4 is necessary and sufficient for disrupting calcium signaling in infected and uninfected cells, affecting disease severity. Manipulating NSP4 could lead to new approaches to prevent or treat rotavirus infections.
Researchers created new proteins using AI that bind to and neutralize deadly snake toxins, providing a safer alternative to traditional antivenoms. The study's results show an 80-100% survival rate in mice, offering potential benefits for people in developing countries.
A recent study highlights the need for targeted interventions to improve COVID-19 vaccine confidence among Black women in the US. Addressing historical traumas and providing clear safety information are crucial to building trust with this demographic.
Research from Radboud University Medical Center shows that lockdowns during the COVID-19 pandemic strengthened the immune system's response to microorganisms. The study found that after lockdowns, inflammation levels in the body were low but the immune system reacted more intensely to viruses and bacteria.
A recent study in the Netherlands has found that COVID-19 vaccination during pregnancy is not associated with adverse health outcomes in infants. The researchers analyzed data from over 3,600 participants and found no significant associations between maternal COVID-19 vaccination and neonatal health issues, including breathing difficul...
UC San Diego researchers identified the key reason for vaccine failures against Staphylococcus aureus: overabundance of interleukin-10 (IL-10) in B cells and helper T cells. Blocking IL-10 restores vaccine efficacy, suggesting a potential solution to combat this deadly bacterium.
Researchers created an advanced computational model to optimize maternal vaccine design and protect high-risk populations. The model helps reveal which antibodies can pass through effectively and when, enabling the development of safer, more effective vaccines.
The University of Arizona Health Sciences has received a second vote of support from Maricopa County, doubling its investment in the Center for Advanced Molecular and Immunological Therapies (CAMI) to $8 million. CAMI will accelerate novel therapies for cancers, autoimmune conditions, and infectious diseases, including COVID-19.
The study found that early initiation of the HPV vaccine series led to significant improvements in vaccination rates across all racial and ethnic groups. Vaccination rates increased from 13.2% in 2019 to 42.2% in 2022, with notable increases for Hispanic or Latino, Black, Asian, and white patients.
A study published in PLOS Global Public Health found that individuals with high credulity are more susceptible to fake news and vaccine hesitancy. Mistrust was also linked to conspiracy thinking and difficulty distinguishing between real and fake news, particularly in those exposed to childhood adversity.
A recent study published in Nature found that mother fleas can transmit the plague to their offspring, posing a significant threat to prairie dog colonies and other rodent populations. This discovery highlights the importance of understanding the role of animals in the dissemination of the disease.
Researchers found that brief scientific literacy interventions can undermine conspiracy beliefs, particularly those built on faulty reasoning. These interventions were most effective against novel conspiracies and among high-conspiracy groups.
The study utilized biocompatible polymethyl methacrylate microspheres for controlled antigen delivery, demonstrating improved immunogenicity of tetanus toxoid. Microsphere formulations showed significant immune response, with optimal polymer concentrations required to meet I.P. requirements.
Researchers at MUSC Hollings Cancer Center found a significant reduction in cervical cancer deaths among young women due to HPV vaccination. The study revealed a 62% decline in mortality rates over the last decade.
A significant drop in cervical cancer mortality among US women younger than age 25 has been observed, according to a recent study published in JAMA Network. The findings indicate that widespread HPV vaccination is driving this decline, reducing the prevalence of HPV infection and subsequent cervical cancer incidence.
A modeling study found that HPV vaccination programs for adults aged 27-45 years are more costly and less effective than vaccinating younger people. Vaccinating subgroups at higher risk of HPV infection may improve cost-effectiveness, but overall, it's unlikely to be efficient for cancer prevention.
Researchers at Scripps Research have analyzed the molecular structure of viral proteins and developed a more stable form to create effective vaccines. The new design may lead to combination vaccines that target both RSV and human metapneumovirus, reducing hospitalizations for vulnerable populations.
Researchers developed biocompatible polymethyl methacrylate microspheres for controlled antigen delivery. The formulation resulted in efficient uptake by macrophages and other antigen-presenting cells, eliciting a notable immune response.
A recent study found that electronic letter reminders highlighting the cardiovascular benefits of influenza vaccines increased vaccination rates among over 2 million adults in Denmark. The strategy showed a greater impact on those who have had a heart attack, improving flu shot rates by potentially being cardioprotective. The research ...
Researchers have made significant strides toward creating inhalable mRNA medicines using a novel lipid-polymer nanoparticle. The nanoparticles successfully deliver aerosols to mice's lungs and demonstrate uniform protein expression in tissues.
Researchers found that vaccinating earlier in pregnancy, closer to 32 weeks, could provide better protection against RSV for newborns. Maternal vaccination resulted in significantly higher and longer-lasting maternal and cord RSV antibody levels.